Energy Scheduling and Performance Evaluation of an e-Vehicle Charging Station

This paper proposes an energy management system (EMS) for a photovoltaic (PV) grid-connected charging station with a battery energy storage system (BESS). The main objective of this EMS is to manage the energy delivered to the electric vehicle (EV), considering the price and (Formula presented.) emissions due to the grid’s connection. Thus, we present a multi-objective two-stage optimization to reduce the impact of the charging station on the environment, as well as the costs. The first stage of the optimization provides an energy schedule, taking into account the PV forecast, the hourly grid’s (Formula presented.) emissions factor, the electricity price, and the initial state of charge of the BESS. The output from this first stage corresponds to the maximum power permitted to be delivered to the EV by the grid. Then, the second stage of the optimization is based on model predictive control that looks to manage the energy flow from the grid, the PV, and the BESS. The proposed EMS is validated using an actual PV/BESS charging station located at the University of Trieste, Italy. Then, this paper presents an analysis of the performance of the charging station under the new EMS considering three main aspects, economic, environmental, and energy, for one month of data. The results show that due to the proposed optimization, the new energy profile guarantees a reduction of 32% in emissions and 29% in energy costs

Facing metal stress by multiple strategies: morphophysiological responses of cardoon (Cynara cardunculus L.) grown in hydroponics

The contamination of environments by heavy metals has become an urgent issue causing undesirable accumulations and severe damages to agricultural crops, especially cadmium and lead which are among the most widespread and dangerous metal pollutants worldwide. The selection of proper species is a crucial step in many plant-based restoration approaches; therefore, the aim of the present work was to check for early morphophysiological responsive traits in three cultivars of Cynara cardunculus (Sardo, Siciliano, and Spagnolo), helping to select the best performing cultivar for phytoremediation. For all three tested cultivars, our results indicate that cardoon displays some morphophysiological traits to face Cd and Pb pollution, particularly at the root morphology level, element uptake ability, and photosynthetic pigment content. Other traits show instead a cultivar-specific behavior; in fact, stomata plasticity, photosynthetic pattern, and antioxidant power provide different responses, but only Spagnolo cv. achieves a successful strategy attaining a real resilience to metal stress. The capacity of Spagnolo plants to modify leaf structural and physiological traits under heavy metal contamination to maintain high photosynthetic efficiency should be considered an elective trait for its use in contaminated environments

Therapeutic and Metagenomic Potential of the Biomolecular Therapies against Periodontitis and the Oral Microbiome: Current Evidence and Future Perspectives

The principles of periodontal therapy are based on the control of microbial pathogens and host factors that contribute to biofilm dysbiosis, with the aim of modulating the progression of periodontitis and periodontal tissue destruction. It is currently known how differently each individual responds to periodontal treatment, depending on both the bacterial subtypes that make up the dysbiotic biofilm and interindividual variations in the host inflammatory response. This has allowed the current variety of approaches for the management of periodontitis to be updated by defining the goals of target strategies, which consist of reducing the periodontopathogenic microbial flora and/or modulating the host-mediated response. Therefore, this review aims to update the current variety of approaches for the management of periodontitis based on recent target therapies. Recently, encouraging results have been obtained from several studies exploring the effects of some targeted therapies in the medium- and long-term. Among the most promising target therapies analyzed and explored in this review include: cell-based periodontal regeneration, mediators against bone resorption, emdogain (EMD), platelet-rich plasma, and growth factors. The reviewed evidence supports the hypothesis that the therapeutic combination of epigenetic modifications of periodontal tissues, interacting with the dysbiotic biofilm, is a key step in significantly reducing the development and progression of disease in periodontal patients and improving the therapeutic response of periodontal patients. However, although studies indicate promising results, these need to be further expanded and studied to truly realize the benefits that targeted therapies could bring in the treatment of periodontitis

Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up

AbstractHuman immunodeficiency virus (HIV) -infected patients with HIV RNA loads of < 50 copies/mL were followed-up for a median (interquartile range) of 30.8 (11.7–32.9) months to study the effect of residual viraemia (RV) on virological rebound (VR). At baseline, 446 (60.3%) patients had undetectable HIV RNA (group A) and 293 (39.7%) had RV (1–49 HIV RNA copies/mL, group B) by kinetic PCR. VR occurred in 4 (0.9%) patients in group A and in 12 (4.1%) patients in group B (p 0.007). Time to VR was shorter among patients of group B (Log-rank test: p 0.003). However, the proportion of VR was extremely low also among patients with RV

Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients

Background: Cerebrospinal fluid (CSF) viral escape is a concern in ritonavir-boosted protease inhibitors monotherapy. The aim was to assess HIV-RNA, biomarkers of immune activation and neurodegeneration, and atazanavir concentrations in CSF of patients on successful long-term atazanavir/ritonavir (ATV/r) monotherapy. Methods: This is a substudy of the multicentric, randomized, open-label, noninferiority trial monotherapy once a day with atazanavir/ritonavir (NCT01511809), comparing the ongoing ATV/r along with 2 nucleoside retrotranscriptase inhibitors (NRTIs) regimen to a simplified ATV/r monotherapy. Patients with plasma HIV-RNA < 50 copies/mL after at least 96 study weeks were eligible. We assessed HIV-RNA, soluble (s)CD14, sCD163, CCL2, CXCL10, interleukin-6, and YKL40 by enzyme-linked immunosorbent assay; neopterin, tryptophan, kynurenine, and neurofilament by immunoassays; and ATV concentrations by liquid chromatography–mass spectrometry in paired plasma and CSF samples. Variables were compared with Wilcoxon rank-sum or Fisher exact test, as appropriate. Results: HIV-RNA was detected in the CSF of 1/11 patients on ATV/r monotherapy (114 copies/mL), without neurological symptoms, who was successfully reintensified with his previous 2NRTIs, and in none of the 12 patients on ATV/r + 2NRTIs. CSF biomarkers and ATV concentrations did not differ between the 2 arms. Conclusions: CSF escape was uncommon in patients on long-term ATV/r monotherapy and was controlled with reintensification

Advancements in Designing the DEMO Driver Blanket System at the EU DEMO Pre-Conceptual Design Phase: Overview, Challenges and Opportunities

The EU conducted the pre-conceptual design (PCD) phase of the demonstration reactor (DEMO) during 2014–2020 under the framework of the EUROfusion consortium. The current strategy of DEMO design is to bridge the breeding blanket (BB) technology gaps between ITER and a commercial fusion power plant (FPP) by playing the role of a “Component Test Facility” for the BB. Within this strategy, a so-called driver blanket, with nearly full in-vessel surface coverage, will aim at achieving high-level stakeholder requirements of tritium self-sufficiency and power extraction for net electricity production with rather conventional technology and/or operational parameters, while an advanced blanket (or several of them) will aim at demonstrating, with limited coverage, features that are deemed necessary for a commercial FPP. Currently, two driver blanket candidates are being investigated for the EU DEMO, namely the water-cooled lithium lead and the helium-cooled pebble bed breeding blanket concepts. The PCD phase has been characterized not only by the detailed design of the BB systems themselves, but also by their holistic integration in DEMO, prioritizing near-term solutions, in accordance with the idea of a driver blanket. This paper summarizes the status for both BB driver blanket candidates at the end of the PCD phase, including their corresponding tritium extraction and removal (TER) systems, underlining the main achievements and lessons learned, exposing outstanding key system design and R&D challenges and presenting identified opportunities to address those risks during the conceptual design (CD) phase that started in 2021